BPC 157 5mg

Contents

Use this guide as a structured review page. The same headings appear for every protocol so clients and the care team can scan the page consistently.

Quickstart Highlights

BPC-157 (pentadecapeptide) is widely studied preclinically for cytoprotection, angiogenesis, and tissue repair mechanisms. Human dosing standards are not established; the schedules below reflect commonly referenced research practices, not medical advice.

• Typical research schedules: 200–300 mcg once daily (Standard) or 250 mcg twice daily (Advanced)
• Reconstitution: Standard: 3 mL (1.67 mg/mL); Advanced: 2 mL (2.5 mg/mL)
• Units on 100-unit insulin syringes: Standard: 200–300 mcg → 12–18 units; Advanced: 250 mcg → 10 units
• Cycle length: 4–8 weeks depending on research design
• Storage: Lyophilized at −20 to −80 °C; after reconstitution 2–8 °C; avoid freeze–thaw
• Compliance: Research use only. Not approved for human use; prohibited in sport by WADA.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

• Why 3 mL? Using the largest reconstitution volume helps keep per-injection measurements at or above ~10 units for accuracy on 100-unit syringes. If a design requires ≤150 mcg per injection (≈9 units at this dilution), consider 30- or 50-unit syringes.

Reconstitution Steps

Using 2.0 mL yields 25 mcg per unit, keeping twice-daily injections at practical volumes while staying above ~10 units per injection.

• Draw 3.0 mL of bacteriostatic water into a sterile syringe.
• Inject slowly along the vial wall to minimize foaming; gently swirl (do not shake).
• Label with concentration (1.67 mg/mL), preparation date, and storage conditions.
• Refrigerate at 2–8 °C and protect from light.
• Draw 2.0 mL of bacteriostatic water into a sterile syringe.
• Inject slowly; gently swirl to dissolve completely.
• Clearly mark concentration (2.5 mg/mL) and store at 2–8 °C, protected from light.

Supplies Needed

Approximate quantities for common 4–8 week designs.

• Peptide Vials (BPC-157 5mg):• 6 wks Standard ≈ 2 vials (≈9.8 mg total)• 8 wks Standard ≈ 3 vials (≈14 mg)• 8 wks Advanced (2×/day) ≈ 6 vials (≈28 mg)
• Insulin Syringes:• 6 wks 1×/day ≈ 42• 8 wks 1×/day ≈ 56• 8 wks 2×/day ≈ 112
• Bacteriostatic Water: 2–3× 10 mL bottles (reconstitute each vial with 2–3 mL)
• Alcohol Swabs: 1 box

Protocol Overview

Concise summary of two commonly referenced research schedules designed for practical syringe measurements.

• Standard: 200–300 mcg once daily (3 mL dilution keeps ≥10 units)
• Advanced: 250 mcg twice daily (2 mL dilution → 10 units per injection)
• Cycle: 4–8 weeks depending on study aim and observations
• Reconstitution: ≤3 mL per vial; record concentration on label
• Storage: Lyophilized at −20 to −80 °C; reconstituted at 2–8 °C; avoid freeze–thaw

Dosing Protocol

Design notes for daily subcutaneous administrations in research contexts.

• Per-injection targets: 200–300 mcg (Standard) or 250 mcg (Advanced, 2×/day)
• Frequency: 1× daily (Standard) or 2× daily (Advanced)
• Timing: Consistent timing from day to day improves study comparability
• Escalation: If escalating from 200→300 mcg, maintain per-injection units ≥10
• Documentation: Log lot numbers, concentrations, and injection sites

Storage Instructions

Follow lab SOPs and manufacturer guidance.

• Lyophilized: Store sealed at −20 to −80 °C; allow to reach room temp before opening to avoid moisture uptake
• Reconstituted: Store at 2–8 °C; aliquot to avoid repeated freeze–thaw
• BUD context: Compounding references (USP <797>) note 28-day limits for preserved multi-dose containers when properly prepared and stored; follow your SOPs

Important Notes

Reference-derived details for BPC 157 5mg.

• Research-only: Not approved for human or veterinary use. Pure Lab Peptides products are for research purposes only.
• Sport compliance: BPC-157 is prohibited by WADA; researchers working with athletes must observe anti-doping regulations.
• Measurement precision: Keep per-injection readings ≥~10 units when feasible; consider 30-/50-unit syringes if designing ≤150 mcg doses.
• Site rotation & asepsis: Rotate injection sites and maintain sterile technique per lab protocols.

How This Works

Key mechanisms reported in preclinical literature:

• Angiogenesis: Engagement of VEGFR2–Akt–eNOS signaling; pro-angiogenic effects in ischemia and tube-formation assays
• NO System Modulation: Endothelium-dependent vasodilation influenced by nitric-oxide pathways
• Cytoprotection: Protection of GI mucosa and multi-organ tissues consistent with “cytoprotection” frameworks
• Tendon/Soft-Tissue Models: Accelerated healing and cell migration in tendon and myotendinous junction studies
• Preclinical studies have reported improved healing markers in GI and musculoskeletal models; robust human safety/efficacy data are limited. Observed considerations in research contexts may include:
• Injection-site irritation or erythema
• Unknown long-term systemic effects; dose–response in humans is not established
• Regulatory and anti-doping compliance requirements

Lifestyle Factors

To improve reproducibility and data quality:

• Standardize timing, injection technique, and site rotation
• Document concurrent variables (diet, activity protocols, recovery periods)
• Use validated outcome measures and consistent follow-up intervals

Injection Technique

General laboratory guidance for subcutaneous administrations:

• Clean stopper & target area with alcohol swabs; use new sterile syringes
• Insert needle at ~45–90° into subcutaneous tissue and inject slowly
• Dispose of sharps per institutional biosafety procedures

Recommended Source

We recommend Prime Lab Peptides for high-purity BPC-157 (5mg).

• Independent lab testing with Certificates of Analysis
• Consistent quality aligned with rigorous manufacturing practices
• Transparent sourcing and responsive researcher support
• Shop at Pure Lab Peptides

Important Note

This page is informational and does not authorize use. Peptify clients should complete assessment, disclose medications and health history, and follow the clinician-approved plan only.

• Do not start, stop, combine, or change a protocol based only on website content.
• Emergency symptoms require urgent medical care, not a website or routine follow-up message.

References

— Emerging use of BPC-157; regulatory context & safety overview

• BPC-157 (5mg Vial) Open source
• — BPC-157 prohibited status & safety cautions
• Journal of Pharmacological Sciences — Klicek R et al. BPC-157 promotes colocutaneous fistula healing via NO-system modulation (rat model) View Source Open source
• Pharmaceuticals (MDPI) — Józwiak M et al. Multifunctionality and possible medical application of BPC-157: literature and patent review (2025) View Source Open source
• Current Pharmaceutical Design (PMC) — Sikiric P et al. BPC-157 stable gastric pentadecapeptide: novel therapy for wound healing and tissue repair View Source Open source
• Life Sciences — Seiwerth S et al. BPC-157 and standard angiogenic growth factors: gastrointestinal tract healing and beyond View Source Open source
• HSS Journal (PubMed) — Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: systematic review (2025) View Source Open source
• Journal of Orthopaedic Research — Chang CH et al. BPC-157 promotes tendon-to-bone healing in a rat rotator cuff model View Source Open source
• WHO (NCBI Bookshelf) — Guideline on safety-engineered syringes for IM, ID, and SC injections in health care settings (2016) View Source Open source
• Johns Hopkins Arthritis Center — How to give a subcutaneous injection (patient education resource) View Source Open source
• ClinicalTrials.gov — NCT02637284: PCO-02 Phase I safety and pharmacokinetics trial of oral BPC-157 View Source Open source
• CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) View Source Open source
• Subcutaneous Drug Injection Review (PMC) — Pharmacologic considerations of the subcutaneous route View Source Open source
• World Journal of Gastroenterology (PMC) — Sikiric P et al. Pentadecapeptide BPC-157: from GI tract to whole body healing View Source Open source
• Prime Lab Peptides — BPC-157 (5 mg) product page (quality and batch documentation) View Source